BPC-157 and TB-500: Research Overview
By UK Peptide Lab Research Team•7 May 2026•8 min read
Overview
BPC-157 and TB-500 are two of the most extensively studied research peptides in preclinical tissue-repair literature. Although both are commonly examined in the context of repair signalling, they are mechanistically distinct molecules. Researchers in the UK can source both BPC-157 5mg and TB-500 5mg from UK Peptide Lab with full third-party HPLC documentation.
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a protective protein found in human gastric juice. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. BPC-157 is unusual among peptides for its stability in acidic gastric environments, which makes it a robust subject for in-vitro and in-vivo research designs.
What is TB-500?
TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), a 43-amino-acid protein found in blood platelets, wound fluid, and virtually all nucleated mammalian cells. TB-500 contains the active actin-binding domain responsible for cell motility, sequestering G-actin monomers and regulating cytoskeletal dynamics.
Mechanistic Differences
BPC-157 is believed to act primarily at local injury sites through angiogenic and nitric-oxide-pathway mechanisms. Research has examined its interactions with VEGF expression, growth-factor signalling, and the nitric oxide system in models of tendon, ligament, and gastrointestinal mucosal repair.
TB-500 acts systemically by sequestering G-actin monomers and regulating cytoskeletal dynamics, promoting cell migration throughout the body. Research has focused on its role in cardiac tissue repair following ischaemic events, dermal wound models, corneal epithelium, and hair follicle biology.
Combined Research Protocols
BPC-157 and TB-500 are frequently studied together in preclinical tissue-repair research. The pairing is rationalised on complementary mechanisms, BPC-157's local angiogenic and nitric-oxide effects alongside TB-500's systemic actin regulatory and cell migration properties. Researchers studying repair signalling pathways often use both compounds to examine potential synergistic interactions at the cellular level. The two should not be mixed in the same vial unless protocols specifically require it, as this complicates concentration calculations.
Laboratory Handling
Both peptides are supplied as lyophilised powders. Store lyophilised vials at -20°C and reconstituted solution at 2-8°C, using within 4 weeks. Reconstitute with bacteriostatic water by injecting slowly down the vial wall and gently swirling, never shake. Aliquot reconstituted stock to avoid repeated freeze-thaw cycles.
Sourcing in the UK
UK Peptide Lab supplies research-grade BPC-157 5mg at 98.6% purity (batch UKPL-216) and TB-500 5mg at 99% purity (batch UKPL-493), both third-party HPLC tested with full lab certificates published on the product pages. Same-day UK dispatch on orders before 2pm GMT. For in-vitro laboratory research only.
Related Products
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. UK Peptide Lab products are not for human consumption and are sold strictly for laboratory research use only.